Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Clinical practice guideline (update): adult sinusitis.Otolaryngol Head Neck Surg. 2015; 152: S1-S39
- Management of Sinusitis in the Cystic Fibrosis patient.Immunol Allergy Clin North Am. 2020; 40: 371-383
- Cystic Fibrosis Foundation Patient Registry.Annual Data Report, 2020: 96 (2020)
- The negative impact of chronic rhinosinusitis on the health-related quality of life among adult patients with Cystic Fibrosis.J Cyst Fibros. 2022;
- Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in Cystic Fibrosis.J Cyst Fibros. 2022;
- Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations.Int Forum Allergy Rhinol. 2022; https://doi.org/10.1002/alr.22974
- Effect of continued medical therapy on productivity costs for refractory chronic rhinosinusitis.JAMA Otolaryngol Head Neck Surg. 2015; 141: 969-973
- Effect of highly effective modulator treatment on sinonasal symptoms in Cystic Fibrosis.J Cyst Fibros. 2021; 20: 460-463
- Impact of CFTR therapy on chronic rhinosinusitis and health status: deep learning ct analysis and patient reported outcomes.Ann Am Thorac Soc. 2022; 19: 12-19
- Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor/tezacaftor/ivacaftor therapy in adults with Cystic Fibrosis.J Cyst Fibros. 2022; https://doi.org/10.1016/j.jcf.2022.03.011
- Olfactory dysfunction in Cystic Fibrosis: impact of CFTR modulator therapy.J Cyst Fibros. 2021;
- Olfaction before and after initiation of elexacaftor-tezacaftor-ivacaftor in a Cystic Fibrosis cohort.Int Forum Allergy Rhinol. 2022; 12: 223-226
- Improvement in sinonasal quality-of-life indicators for pediatric patients with Cystic Fibrosis treated with elexacaftor-tezacaftor-ivacaftor.Int Forum Allergy Rhinol. 2022;
Impact of Sinus Surgery on Individuals With Cystic Fibrosis, NCT04469439. ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT04469439. Accessed 16 July 2022.
- Use of elexacaftor/tezacaftor/ivacaftor among Cystic Fibrosis lung transplant recipients.J Cyst Fibros. 2022;
☆Disclosures: DMB: grant funding from Cystic Fibrosis Foundation, Garner Health, consultant, not related to this work; RJS: PI NIH/NIDCD 1R01DC019078-01A1